Navigation Links
OXIS International Executives Interviewed on StockGoodies.com Radio
Date:10/12/2010

BEVERLY HILLS, Calif., Oct. 12 /PRNewswire/ -- OXIS International, Inc., (OTC Bulletin Board: OXIS; Paris: OXI) today announced that Anthony Cataldo, Chief Executive Officer, and Bernie Landes, President, will be the featured guest interviewees on StockGoodies.com Radio, one of the fastest growing investor and stock trading communities on the Internet.  

The interview will be held on Tuesday, October 12, 2010, at 8:00 p.m. Eastern time, and can be heard at http://www.blogtalkradio.com/stockgoodies.  An archived version can be found on the homepage of www.StockGoodies.com

During the interview, Mr. Cataldo and Mr. Landes are expected to discuss the wide range of benefits provided by OXIS' versatile antioxidant L-Ergothioneine (ERGO), the upcoming launch of two ERGO-based supplements, and the marketing strategy for introducing additional ERGO-based nutraceuticals and cosmeceuticals.

About StockGoodies

StockGoodies, ranked 3rd highest stock related website on Tim Sykes' investimonials.com, is a highly respected, leading publisher of news, perspective, and stock market education on all forms of trading, covering: pennies, micro-cap, small, mid and large cap equities, foreign exchange and options. StockGoodies mission is to educate & empower self-directed investors, with the vision of building a powerhouse of talented traders, helping each other, narrowing the gap between individual and institutional traders.

About OXIS International, Inc.

OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress/inflammation associated with damage from free radical and reactive oxygen species (ROS). The company holds the rights to several therapeutic classes of compounds in the area of oxidative stress, and has focused commercialization programs that include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be sold to the cosmetics markets as well as the functional food and beverage markets.


'/>"/>
SOURCE OXIS International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... to resolve pending patent litigation in the U.S. District Court ... regarding the Cialis ® (tadalafil) unit dose patent. This ... As part of the agreement, Cialis exclusivity is now expected ... "The unit dose patent for Cialis is valid and ...
(Date:7/11/2017)...  Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe ... from painful intercourse and other painful pelvic pain conditions such as pelvic ... ... ... Florida -based start-up company, VuVatech LLC, fills a void in the ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today ... Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at ... Services for the UVA Health System, brings 30 years of highly relevant experience to ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... 20, 2017 , ... For individuals with extended hospital stays or who are ... such facilities are specially designed to accommodate patients with a wide range of ailments ... from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed armrest ...
(Date:7/20/2017)... ... , ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission ... teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One ... “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and ...
(Date:7/20/2017)... Annapolis, MD (PRWEB) , ... July 20, 2017 ... ... Maryland company dedicated to the development of non-invasive devices and systems for monitoring ... $1.5 million. , Proceeds will be used to complete regulatory submissions and fund ...
Breaking Medicine News(10 mins):